Free Trial

Boothbay Fund Management LLC Sells 47,150 Shares of Rentokil Initial plc (NYSE:RTO)

Rentokil Initial logo with Business Services background

Boothbay Fund Management LLC reduced its holdings in Rentokil Initial plc (NYSE:RTO - Free Report) by 53.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 41,286 shares of the company's stock after selling 47,150 shares during the quarter. Boothbay Fund Management LLC's holdings in Rentokil Initial were worth $1,045,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Cape Investment Advisory Inc. boosted its stake in Rentokil Initial by 65.2% in the fourth quarter. Cape Investment Advisory Inc. now owns 1,505 shares of the company's stock valued at $38,000 after acquiring an additional 594 shares during the period. MML Investors Services LLC lifted its position in Rentokil Initial by 0.8% in the 4th quarter. MML Investors Services LLC now owns 90,687 shares of the company's stock valued at $2,296,000 after purchasing an additional 704 shares during the last quarter. Exencial Wealth Advisors LLC boosted its stake in Rentokil Initial by 2.3% during the 4th quarter. Exencial Wealth Advisors LLC now owns 43,532 shares of the company's stock valued at $1,102,000 after purchasing an additional 972 shares during the period. Russell Investments Group Ltd. increased its position in Rentokil Initial by 63.9% in the 4th quarter. Russell Investments Group Ltd. now owns 3,287 shares of the company's stock valued at $83,000 after acquiring an additional 1,281 shares during the period. Finally, Blue Trust Inc. lifted its holdings in Rentokil Initial by 140.4% in the fourth quarter. Blue Trust Inc. now owns 2,402 shares of the company's stock worth $60,000 after purchasing an additional 1,403 shares during the period. 9.91% of the stock is owned by institutional investors and hedge funds.

Rentokil Initial Stock Up 4.2 %

Rentokil Initial stock traded up $0.96 during trading hours on Friday, hitting $23.85. The company had a trading volume of 681,910 shares, compared to its average volume of 774,971. The firm's fifty day moving average is $22.62 and its 200-day moving average is $24.41. The firm has a market capitalization of $12.04 billion, a P/E ratio of 15.79, a price-to-earnings-growth ratio of 7.95 and a beta of 1.07. Rentokil Initial plc has a fifty-two week low of $19.60 and a fifty-two week high of $34.07. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.04 and a quick ratio of 0.96.

Rentokil Initial Announces Dividend

The company also recently declared a semi-annual dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 4th will be paid a dividend of $0.3825 per share. This represents a dividend yield of 2.4%. The ex-dividend date is Friday, April 4th. Rentokil Initial's dividend payout ratio (DPR) is presently 43.71%.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Rentokil Initial in a research note on Friday, March 7th. Three investment analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy".

Get Our Latest Analysis on Rentokil Initial

Rentokil Initial Company Profile

(Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

Read More

Institutional Ownership by Quarter for Rentokil Initial (NYSE:RTO)

Should You Invest $1,000 in Rentokil Initial Right Now?

Before you consider Rentokil Initial, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.

While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines